Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology W orking G roup on M yocardial and P ericardial D iseases

Hot hearts on bone scintigraphy are not all amyloidosis: hydroxychloroquine-induced restrictive cardiomyopathy

(2020) Michael E Layoun et al.   EUROPEAN HEART JOURNAL

Comparison of 2 Serum-Free Light-Chain Assays in CKD Patients

(2020) Ben Sprangers et al.   Kidney International Reports

Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage

(2020) Steven Law et al.   ESC Heart Failure

Systemic Amyloidosis due to Monoclonal Immunoglobulins

(2020) Sunil E. Saith et al.   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Amiloidosis cardíaca por transtiretina

(2020) Pablo Garcia-Pavia et al.   MEDICINA CLINICA

Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy

(2020) Claudio Rapezzi et al.   JACC-Heart Failure

Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee

(2019) Merrill D. Benson et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

Assessment of patients with hereditary transthyretin amyloidosis – understanding the impact of management and disease progression

(2019) Isabel Conceição et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

Transthyretin Amyloid Cardiomyopathy

(2019) Frederick L. Ruberg et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The Challenges in Chemotherapy and Stem Cell Transplantation for Light-Chain Amyloidosis

(2019) Eli Muchtar et al.   CANADIAN JOURNAL OF CARDIOLOGY

Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis

(2019) Michele Boldrini et al.   JACC-Cardiovascular Imaging

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

(2018) David Adams et al.   NEW ENGLAND JOURNAL OF MEDICINE

Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis

(2018) Merrill D. Benson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

(2018) Mathew S. Maurer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis

(2018) Brian Lilleness et al.   BLOOD

A new staging system for cardiac transthyretin amyloidosis

(2017) Julian D Gillmore et al.   EUROPEAN HEART JOURNAL

Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement

(2017) Adam Castaño et al.   EUROPEAN HEART JOURNAL

What is new in diagnosis and management of light chain amyloidosis?

(2016) G. Palladini et al.   BLOOD

Nonbiopsy Diagnosis of Cardiac Transthyretin AmyloidosisCLINICAL PERSPECTIVE

(2016) Julian D. Gillmore et al.   CIRCULATION

Analysis of diagnostic and therapeutic strategies in advanced cardiac light-chain amyloidosis

(2016) Inés Sayago et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System

(2016) Martha Grogan et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardiac amyloidosis: pathology, nomenclature, and typing

(2015) Joseph J. Maleszewski   CARDIOVASCULAR PATHOLOGY

Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction

(2015) Esther González-López et al.   EUROPEAN HEART JOURNAL

Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness

(2015) Thibaud Damy et al.   EUROPEAN HEART JOURNAL

Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

(2012) Shaji Kumar et al.   JOURNAL OF CLINICAL ONCOLOGY

Identification of Amyloidogenic Light Chains Requires the Combination of Serum-Free Light Chain Assay with Immunofixation of Serum and Urine

(2009) G. Palladini et al.   CLINICAL CHEMISTRY